Skip to content

Intraoperative Fetal Heart Rate (FHR) Monitoring: a Feasibility Study

Intraoperative Fetal Heart Rate (FHR) Monitoring: a Feasibility Study

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02950896
Enrollment
4
Registered
2016-11-01
Start date
2016-10-31
Completion date
2017-10-29
Last updated
2019-05-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fetal Monitoring, Labor, Obstetric

Brief summary

Fetal heart rate \[FHR\] monitoring is used widely to assess the well-being of the baby in the delivery period. If it is determined that an urgent cesarean delivery is required because of fetal distress, FHR is discontinued once the mother is in the operating room in order to allow for surgical site preparation. From this point, there is no real-time monitoring that permits assessment of the well-being of the infant. The investigators are evaluating the feasibility of intraoperative FHR monitoring using fetal ECG placed on the mother's upper abdominal wall and the standard acoustic device routinely used. The investigators will compare these to the traditional well-being tests: umbilical arterial blood gas and Apgar score. The first 15 subjects will be recruited from pregnant women who have scheduled induction of labor. The subsequent 40 subjects will be recruited from pregnant women who have scheduled cesarean sections.

Detailed description

Fetal heart rate (FHR) monitoring has become the most widely used assessment of fetal well-being in the peripartum period and the only routinely used method that provides continuous fetal monitoring. Despite a false positive rate for the detection of intrapartum asphyxia leading to cerebral palsy of over 99% \[1-3\] FHR monitoring continues to be the mainstay of peripartum fetal surveillance. FHR monitoring is routinely available in the operating room, where it is typically reassessed in cases of urgent cesarean delivery for fetal distress since it may direct immediate anesthetic and peripartum management. However, despite the ubiquitous use of FHR monitoring in labor and the typical use of FHR monitoring on arrival to the OR, FHR monitoring is universally stopped once anesthesia has been performed in order to allow abdominal skin preparation and for surgery to proceed. From the moment of anesthesia induction until fetal delivery, no real-time data is available that allows assessment of fetal well-being. A few isolated studies and case reports in the 1970s-1980s examined intraoperative FHR monitoring using scalp-clip electrodes during Cesarean deliveries \[4-7\]. None of these studies assessed external FHR monitors or current anesthesia techniques. To the investigators' knowledge no studies since that time have examined FHR monitoring during Cesarean deliveries using external monitoring or spinal anesthesia

Interventions

OTHERobservational fetal heart rate monitoring

Patients will have fetal heart rate monitoring

Sponsors

Washington University School of Medicine
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

1. First 15 patients only- Elective induction of labor, not yet in active labor. 2. Subsequent 40 patients - Scheduled cesarean sections performed under spinal anesthesia 3. Patients ages 18-45

Exclusion criteria

1. Urgent or emergent cesarean sections 2. Cesarean sections performed under general anesthesia

Design outcomes

Primary

MeasureTime frameDescription
ECG of Fetal Heart Rate10 minutes of evaluable ECG readingThis measure will be compared to the acoustic monitoring of FHR across the same 10 minutes.

Countries

United States

Participant flow

Participants by arm

ArmCount
Intraoperative FHR Monitoring
Intraoperative fetal heart rate (FHR) monitoring observational fetal heart rate monitoring: Patients will have fetal heart rate monitoring
0
Total0

Baseline characteristics

Characteristic
Age, Customized
18-45 years
Region of Enrollment
United States
— participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 4
other
Total, other adverse events
0 / 4
serious
Total, serious adverse events
0 / 4

Outcome results

Primary

ECG of Fetal Heart Rate

This measure will be compared to the acoustic monitoring of FHR across the same 10 minutes.

Time frame: 10 minutes of evaluable ECG reading

Population: The study was terminated and no results were analyzed.

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026